Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Moodys
McKinsey
Merck
AstraZeneca

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Vinorelbine tartrate - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for vinorelbine tartrate and what is the scope of patent protection?

Vinorelbine tartrate is the generic ingredient in two branded drugs marketed by Pierre Fabre, Actavis Totowa, Dr Reddys, Ebewe Pharma, Fresenius Kabi Usa, Hospira, Jiangsu Hansoh Pharm, Mylan Labs Ltd, Novast Labs, Teva Pharms Usa, and West-ward Pharms Int, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for vinorelbine tartrate. Four suppliers are listed for this compound.

Recent Clinical Trials for vinorelbine tartrate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
KCR S.A.Phase 2
Helix BioPharma CorporationPhase 2
Oncology Therapeutic DevelopmentPhase 2

See all vinorelbine tartrate clinical trials

Pharmacology for vinorelbine tartrate
Drug ClassVinca Alkaloid
Synonyms for vinorelbine tartrate
125317-39-7
253GQW851Q
3',4'-Didehydro-4'-deoxy-8'-norvincaleukoblastine L-(+)-tartrate (1:2) (salt)
3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine [R-(R*,R*)-2-3-dihydroxybutanedioate (1:2)salt]
3',4'-DIDEHYDRO-4'-DEOXY-C'-NORVINCALEUKOBLASTINE R-(R*,R*)-2-3-DIHYDROXYBUTANEDIOATE (1:2) SALT
317V397
3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate bis((2R,3R)-2,3-dihydroxysuccinate)
5'-Noranhydrovinoblastine tartrate
AB15572
AC1L1TWN
AN-569
C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:2) (salt)
C45H54N4O8.2C4H6O6
CAS-125317-39-7
CHEMBL538943
CS-1581
CV0016
D01935
DSSTox_CID_27802
DSSTox_GSID_47825
DSSTox_RID_82572
DTXSID5047825
H847
HY-12053A
KB-276096
KW 2307
KW-2307
LS-97534
methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl)-5-hydroxy-8-methoxy-6-methyl-3a,
Methyl (3aR,4R,5S,5aR,10bR,13aR)-4-(acetyloxy)-3a-ethyl-9-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methano-2H-azacyclodecino[4,3-b]indol-8-yl]-5-hydroxy-8-methoxy-6-methyl-3a,4,5
MFCD03613607
MolPort-003-986-338
MolPort-035-395-882
MolPort-039-052-359
Navelbine
Navelbine (TN)
Navelbine tartrate
NCGC00165966-02
NCGC00263568-01
Nor-5'-anhydrovinblastine ditartrate
NVB
Q-100110
SCHEMBL16766511
SCHEMBL4334811
SCHEMBL4764
TL8000651
Tox21_112271
Tox21_112271_1
UNII-253GQW851Q
Vinorelbine (ditartrate)
Vinorelbine Bitartarate
Vinorelbine Bitartrate
Vinorelbine Ditartarate
vinorelbine ditartaric acid
vinorelbine ditartate
Vinorelbine ditartrate
Vinorelbine ditartrate (JAN)
VINORELBINE DITARTRATE SALT
vinorelbine L-tartrate
Vinorelbine tartrate (USP)
Vinorelbine tartrate [USAN:USP]
Vinorelbine tartrate [USAN]
vinorelbine, ditartrate

US Patents and Regulatory Information for vinorelbine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076028-001 Feb 3, 2003 AP RX No No   Start Trial   Start Trial   Start Trial
West-ward Pharms Int VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 075992-001 Jun 10, 2003 AP RX No No   Start Trial   Start Trial   Start Trial
Hospira VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076827-001 Jun 2, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
Boehringer Ingelheim
Moodys
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.